Repositioning approved drugs for the treatment of problematic cancers using a screening approach

• Hristo P. Varbanov ,

  * E-mail: hristo.varbanov@univie.ac.at (HPV); paul.dyson@epfl.ch (PJD)

  Affiliations Institut des Sciences et Ingénierie Chimiques, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland, Biomolecular Screening Facility, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland

  http://orcid.org/0000-0003-4450-7332

  ⨯
• Fabien Kuttler,

  Affiliation Biomolecular Screening Facility, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland

  ⨯
• Damiano Banfi,

  Affiliation Biomolecular Screening Facility, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland

  ⨯
• Gerardo Turcatti,

  Affiliation Biomolecular Screening Facility, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland

  ⨯
• Paul J. Dyson

  * E-mail: hristo.varbanov@univie.ac.at (HPV); paul.dyson@epfl.ch (PJD)

  Affiliation Institut des Sciences et Ingénierie Chimiques, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland

  ⨯